150 related articles for article (PubMed ID: 949890)
1. Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers.
Koch UJ; Lorenz F; Danehl K; Ericsson R; Hasan SH; Keyserlingk DV; Lübke K; Mehring M; Römmler A; Schwartz U; Hammerstein J
Contraception; 1976 Aug; 14(2):117-35. PubMed ID: 949890
[TBL] [Abstract][Full Text] [Related]
2. Use of low-dosage oral cyproterone acetate as a male contraceptive.
Wang C; Yeung KK
Contraception; 1980 Mar; 21(3):245-72. PubMed ID: 6771091
[TBL] [Abstract][Full Text] [Related]
3. Effects of cyproterone acetate on reproductive functions in normal human males.
Roy S; Chatterjee S; Prasad MR; Poddar AK; Pandey DC
Contraception; 1976 Oct; 14(4):403-20. PubMed ID: 975826
[TBL] [Abstract][Full Text] [Related]
4. Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.
Moltz L; Römmler A; Post K; Schwartz U; Hammerstein J
Contraception; 1980 Apr; 21(4):393-413. PubMed ID: 6771095
[TBL] [Abstract][Full Text] [Related]
5. Studies with cyproterone acetate for male contraception.
Roy S; Chatterjee S
J Steroid Biochem; 1979 Jul; 11(1B):675-80. PubMed ID: 491632
[TBL] [Abstract][Full Text] [Related]
6. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
Soufir JC; Jouannet P; Marson J; Soumah A
Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
[TBL] [Abstract][Full Text] [Related]
7. The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men.
Føgh M; Corker CS; Hunter WM; McLean H; Philip J; Schou G; Skakkebaek NE
Acta Endocrinol (Copenh); 1979 Jul; 91(3):545-52. PubMed ID: 474042
[TBL] [Abstract][Full Text] [Related]
8. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
[TBL] [Abstract][Full Text] [Related]
9. The influence of pharmaceutical compounds on male fertility.
Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men.
Foegh M; Nicol K; Petersen IB; Schou G
Contraception; 1980 Jun; 21(6):631-40. PubMed ID: 6775869
[TBL] [Abstract][Full Text] [Related]
11. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
Knuth UA; Yeung CH; Nieschlag E
Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
[TBL] [Abstract][Full Text] [Related]
12. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
13. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
14. Cyproterone acetate: II. failure to reduce sperm fertility in the surgically separated epididymis of rat.
Chatterjee A; Pal AK; Ray P; Basu R
Contraception; 1977 Apr; 15(4):429-34. PubMed ID: 880818
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyproterone acetate (CPA) on gonadal and adrenal function in men.
de la Torre B; Norén S; Hedman M; Diczfalusy E
Contraception; 1979 Oct; 20(4):377-96. PubMed ID: 228907
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.
Cooper AJ; Sandhu S; Losztyn S; Cernovsky Z
Can J Psychiatry; 1992 Dec; 37(10):687-93. PubMed ID: 1473073
[TBL] [Abstract][Full Text] [Related]
17. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E
Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
[TBL] [Abstract][Full Text] [Related]
18. Effect of administration of a single dose of testosterone oenanthate on constituents of human seminal plasma and serum gonadotropins.
Sheth AR; Jayatilak PG; Thakur AN; Mugatwala P; Pardanani DS
Andrologia; 1976; 8(3):259-64. PubMed ID: 999044
[TBL] [Abstract][Full Text] [Related]
19. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
Meriggiola MC; Bremner WJ; Paulsen CA; Valdiserri A; Incorvaia L; Motta R; Pavani A; Capelli M; Flamigni C
J Clin Endocrinol Metab; 1996 Aug; 81(8):3018-23. PubMed ID: 8768868
[TBL] [Abstract][Full Text] [Related]
20. Effects of low doses of cyproterone acetate on sperm morphology and some other parameters of reproduction in normal men.
Fredricsson B; Carlström K
Andrologia; 1981; 13(4):369-75. PubMed ID: 6456681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
